T. Nagahata et al., EFFECT OF OXETANOCIN-G, A NOVEL NUCLEOSIDE ANALOG, ON DNA-SYNTHESIS BY HEPATITIS-B VIRUS VIRIONS, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 707-712
The novel nucleoside oxetanocin G, -2-hydroxymethyl-beta-D-erythro-oxe
tanosyl)guanine (OXT-G), that is a derivative of oxetanocin A, was stu
died in relation to its action on the synthesis of hepatitis B virus (
HBV) DNA and cellular DNA in an HBV-producing cell line, HB611 (T. Tsu
rimoto, A. Fujiyama, and K. Matsubara, Proc. Natl. Acad. Sci. USA 84:4
44-448, 1987). The median effective concentration of OXT-G against HBV
replication was 1.5 muM, and the median cytotoxic concentration was m
ore than 1,000 muM. At the same concentration, OXT-G did not inhibit c
ellular DNA synthesis or viral RNA synthesis. Chemically synthesized O
XT-GTP inhibited the HBV endogenous DNA polymerase reaction and was in
corporated into HBV DNA strands at a low efficiency compared with the
incorporation of dGTP. A synthetic primer-template study revealed that
OXT-GTP was incorporated into DNA strands at a low efficiency and tha
t further extension of the DNA strand by using the 2' position of the
incorporated OXT-G could take place.